Cerebral sinus venous thrombosis (CSVT) is a recognized cause of childhood and neonatal stroke. More than 50% of neonates have a poor outcome, and mortality is high. Coma is a predictor of death in neonatal CSVT. We present the case of a 9-day-old infant, who presented in coma and was treated successfully with a combination of mechanical thrombectomy using the MindFrame System via the right jugular vein, local infusion of recombinant tissue plasminogen activator and abciximab, as well as anticoagulation. In this case, aggressive thrombectomy and thrombolysis achieved complete neurologic restoration safely and quickly.

Keywords:
Technique, Sinus thrombosis, Thrombectomy, Thrombolysis, Abciximab, Endovascular thrombolysis, Newborn, Tissue plasminogen activator
1.
Berfelo FJ, Kersbergen KJ, van Ommen CH, Govaert P, van Straaten HL, Poll-The BT, van Wezel-Meijler G, Vermeulen RJ, Groenendaal F, de Vries LS, de Haan TR: Neonatal cerebral sinovenous thrombosis from symptom to outcome. Stroke 2010;41:1382-1388.
2.
Sèbire G, Tabarki B, Saunders DE: Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain 2005;128:477-489.
3.
Griesemer DA, Theodorou AA, Berg RA: Local fibrinolysis in cerebral venous thrombosis. Pediatr Neurol 1994;10:78-80.
4.
Liebetrau M, Mayer TE, Bruning R: Intra-arterial thrombolysis of complete deep cerebral venous thrombosis. Neurology 2004;63:2444-2445.
5.
Khan IS, Ladner TR, Satti KF, Ehtesham M, Jordan LC, Singer RJ: Endovascular thrombolysis for pediatric cerebral sinus venous thrombosis with tissue plasminogen activator and abciximab. J Neurosurg Pediatr 2014;13:68-71.
6.
Rammos SK, Phillips J, Lin J, Moresco K, Meagher S: Successful rheolytic mechanical thrombectomy of cerebral venous thrombosis in a pediatric patient. J Neurosurg Pediatr 2013;11:140-143.
7.
Keller E, Pangalu A, Fandino J, et al: Decompressive craniectomy in severe cerebral venous and dural sinus thrombosis. Acta Neurochir Suppl 2005;94:177-183.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.